Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 244

1.

Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).

Friberg L, Hammar N, Rosenqvist M.

Heart. 2010 Feb;96(4):275-80. doi: 10.1136/hrt.2009.175786. Epub 2009 Aug 25.

PMID:
19710030
2.

Digoxin and mortality in atrial fibrillation: a prospective cohort study.

Hallberg P, Lindbäck J, Lindahl B, Stenestrand U, Melhus H; RIKS-HIA group.

Eur J Clin Pharmacol. 2007 Oct;63(10):959-71. Epub 2007 Aug 8.

PMID:
17684738
3.

Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF).

Friberg L, Hammar N, Pettersson H, Rosenqvist M.

Eur Heart J. 2007 Oct;28(19):2346-53. Epub 2007 Aug 1.

4.
5.

Atrial fibrillation after cardiac surgery: a major morbid event?

Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, Tarazi R, Shroyer AL, Sethi GK, Grover FL, Hammermeister KE.

Ann Surg. 1997 Oct;226(4):501-11; discussion 511-3.

6.

Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.

Turakhia MP, Santangeli P, Winkelmayer WC, Xu X, Ullal AJ, Than CT, Schmitt S, Holmes TH, Frayne SM, Phibbs CS, Yang F, Hoang DD, Ho PM, Heidenreich PA.

J Am Coll Cardiol. 2014 Aug 19;64(7):660-8. doi: 10.1016/j.jacc.2014.03.060.

7.

Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.

Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.

Circ Arrhythm Electrophysiol. 2012 Apr;5(2):312-8. doi: 10.1161/CIRCEP.111.967000. Epub 2012 Feb 7.

8.

Should digoxin be proscribed in elderly subjects in sinus rhythm free from heart failure? A population-based study.

Casiglia E, Tikhonoff V, Pizziol A, Onesto C, Ginocchio G, Mazza A, Pessina AC.

Jpn Heart J. 1998 Sep;39(5):639-51.

PMID:
9925995
9.

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB.

J Am Coll Cardiol. 2005 Mar 1;45(5):705-11.

10.
11.

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowitz SD, Nessel CC, Fox KA, Califf RM, Piccini JP, Patel MR; ROCKET AF Steering Committee and Investigators.

Lancet. 2015 Jun 13;385(9985):2363-70. doi: 10.1016/S0140-6736(14)61836-5. Epub 2015 Mar 6.

PMID:
25749644
12.

Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure.

Pedersen OD, Søndergaard P, Nielsen T, Nielsen SJ, Nielsen ES, Falstie-Jensen N, Nielsen I, Køber L, Burchardt H, Seibaek M, Torp-Pedersen C; DIAMOND study group investigators.

Eur Heart J. 2006 Dec;27(23):2866-70. Epub 2006 Nov 13.

13.

Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.

Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran K.

J Heart Lung Transplant. 2006 Jan;25(1):53-60. Epub 2005 Nov 2.

PMID:
16399531
14.

Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.

Winkel TA, Hoeks SE, Schouten O, Zeymer U, Limbourg T, Baumgartner I, Bhatt DL, Steg PG, Goto S, Röther J, Cacoub PP, Verhagen HJ, Bax JJ, Poldermans D.

Eur J Vasc Endovasc Surg. 2010 Jul;40(1):9-16. doi: 10.1016/j.ejvs.2010.03.003. Epub 2010 Apr 10.

15.

Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.

Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Behlouli H, Pilote L.

Am J Cardiol. 2014 Aug 1;114(3):401-6. doi: 10.1016/j.amjcard.2014.05.013. Epub 2014 May 16.

PMID:
24950677
16.

Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.

Hemels ME, Van Noord T, Crijns HJ, Van Veldhuisen DJ, Veeger NJ, Bosker HA, Wiesfeld AC, Van den Berg MP, Ranchor AV, Van Gelder IC.

J Am Coll Cardiol. 2006 Sep 5;48(5):1001-9. Epub 2006 Aug 17.

17.

Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up.

Berton G, Cordiano R, Cucchini F, Cavuto F, Pellegrinet M, Palatini P.

Int J Clin Pract. 2009 May;63(5):712-21. doi: 10.1111/j.1742-1241.2009.02023.x.

PMID:
19392921
18.

Effects of atrial fibrillation on long-term outcomes in patients hospitalized for heart failure in Japan: a report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

Hamaguchi S, Yokoshiki H, Kinugawa S, Tsuchihashi-Makaya M, Yokota T, Takeshita A, Tsutsui H; Japanese Cardiac Registry of Heart Failure in Cardiology Investigators.

Circ J. 2009 Nov;73(11):2084-90. Epub 2009 Sep 15.

19.

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.

Gheorghiade M, Fonarow GC, van Veldhuisen DJ, Cleland JG, Butler J, Epstein AE, Patel K, Aban IB, Aronow WS, Anker SD, Ahmed A.

Eur Heart J. 2013 May;34(20):1489-97. doi: 10.1093/eurheartj/eht120. Epub 2013 Apr 16.

20.

Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.

Fauchier L, Grimard C, Pierre B, Nonin E, Gorin L, Rauzy B, Cosnay P, Babuty D, Charbonnier B.

Am J Cardiol. 2009 Jan 15;103(2):248-54. doi: 10.1016/j.amjcard.2008.09.064. Epub 2008 Nov 7.

PMID:
19121446
Items per page

Supplemental Content

Write to the Help Desk